Roche Enlists HHS As Promotion Partner For Tamiflu Corporate Stockpile Effort
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche is moving to a new strategy for its Tamiflu U.S. stockpile program: the next target after government entities is large corporations, and HHS is helping Roche reach those customers.
You may also be interested in...
Tamiflu Drags On Roche’s First Quarter Sales
Sales of Rituxan, Herceptin, Avastin and Boniva increase by double digits.
Tamiflu, Relenza Labels Adjusted To Cite Influenza As Potential Cause Of Neuro Events
Roche says label change for Tamiflu reflects growing evidence there is no causal relationship between the drug and neuropsychiatric events.
Big Pharma Still Hopeful For Next Mega Drugs To Supplement Sales
Drug makers need to continue investing in early-stage research to unveil the next $1 billion-plus drug, panelists at the Argyle conference agree.